Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine

Vaccine
Wendell D ZollingerPaul B Keiser

Abstract

A vaccine based on native outer membrane vesicles (NOMV) that has potential to provide safe, broad based protection against group B strains of Neisseria meningitidis has been developed. Three antigenically diverse group B strains of N. meningitidis were chosen and genetically modified to improve safety and expression of desirable antigens. Safety was enhanced by disabling three genes: synX, lpxL1, and lgtA. The vaccine strains were genetically configured to have three sets of antigens each with potential to induce protective antibodies against a wide range of group B strains. Preliminary immunogenicity studies with combined NOMV from the three strains confirmed the capacity of the vaccine to induce a broad based bactericidal antibody response. Analysis of the bactericidal activity indicated that antibodies to the LOS were responsible for a major portion of the bactericidal activity and that these antibodies may enhance the bactericidal activity of anti-protein antibodies.

References

Jan 1, 1982·Analytical Biochemistry·C M Tsai, C E Frasch
May 5, 1999·JAMA : the Journal of the American Medical Association·J W TapperoB A Perkins
Jun 5, 2002·The Journal of Experimental Medicine·Maurizio ComanducciMarirosa Mora
Mar 19, 2003·The Journal of Experimental Medicine·Vega MasignaniMariagrazia Pizza
Jan 19, 2006·Clinical Microbiology Reviews·Lee H Harrison
Jul 11, 2006·Proceedings of the National Academy of Sciences of the United States of America·Marzia M GiulianiMariagrazia Pizza
Jun 2, 2009·Vaccine·Ian M Feavers, Mariagrazia Pizza
Jun 3, 2009·Expert Review of Vaccines·Susan LewisAndrew J Pollard
Oct 16, 2009·Clinical and Vaccine Immunology : CVI·Wendell D ZollingerDeborah H Schmiel

❮ Previous
Next ❯

Citations

Dec 15, 2010·Seminars in Immunopathology·Can M UnalKristian Riesbeck
Sep 13, 2011·PLoS Neglected Tropical Diseases·Rolando PajonDan M Granoff
Sep 7, 2013·Journal of Extracellular Vesicles·Kenneth W WitwerFred Hochberg
Jan 24, 2016·Vaccine·Merijn L M SalverdaPeter van der Ley
Sep 17, 2011·Expert Review of Vaccines·Donatella PanattoRoberto Gasparini
Mar 26, 2011·Expert Review of Vaccines·Alice Deasy, Robert C Read
May 25, 2011·Expert Review of Vaccines·Annaliesa S AndersonJoseph Eiden
Dec 22, 2012·Expert Review of Vaccines·Holly SandersGermie Pjm van den Dobbelsteen
Mar 4, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Jenny Fernebro
Sep 6, 2012·Tropical Medicine & International Health : TM & IH·Ray Borrow
Aug 12, 2015·Pathogens and Disease·María Emilia GaillardDaniela Hozbor
Aug 16, 2016·Journal of Pharmaceutical Sciences·Patrick L AhlJeffrey T Blue
Feb 16, 2013·Journal of Proteome Research·Bas van de WaterbeemdAd P J M de Jong
Apr 4, 2017·Pathogens and Disease·Myron Christodoulides, John Heckels
Jul 20, 2014·Applied and Environmental Microbiology·Maria H Daleke-SchermerhornJoen Luirink
Mar 31, 2012·Clinical and Vaccine Immunology : CVI·Elizabeth E MoranValerian B Pinto
Jan 31, 2014·Expert Review of Vaccines·Roberto GaspariniDonatella Panatto
Mar 24, 2015·Expert Review of Vaccines·Afshin Zariri, Peter van der Ley
Nov 1, 2013·The Journal of Microbiology·Byeong-Jae LeeYoung Ki Choi
May 8, 2020·Microbial Genomics·Joseph J WanfordLuke R Green
Apr 23, 2010·The New England Journal of Medicine·Lionel K K TanRay Borrow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.